|
|
|
Thursday, 23 May 2013 08:26 |
Follow us on Twitter and Facebook for the latest Class Action Lawsuit Settlement News!
Penguin Announces $75M E-Book Pricing Class Action Settlement
By Matt O'Donnell
 Penguin, the last remaining defendant to settle state and consumer lawsuits accusing it of driving up the price of e-books, has finally reached a class action lawsuit settlement. The book publisher announced yesterday it will pay $75 million to resolve claims it conspired with Apple and other publishers to fix and raise the prices of electronic books.
The Penguin settlement marks the end to a massive litigation involving 33 state attorneys general as well as a class action lawsuit filed by consumers who accuse the book publishers of violating antitrust laws and causing consumers to overpay for e-books. Macmillan and Penguin held out in settling their portion of the case, while the remaining book publisher defendants -- Simon and Schuster, HarperCollins, Penguin and Hachette – reached settlements last year.
|
|
|
|
Thursday, 23 May 2013 09:19 |
Follow us on Twitter and Facebook for the latest Zithromax Class Action Lawsuit News!
Zithromax May Cause Heart Attack, Other Cardiac Problems
By Robert J. Boumis
 People sometimes forget how revolutionary antibiotics are. For the majority of human history, bacterial infection could strike down anyone. Something as innocuous as strep throat could threaten someone’s life, without the safety net of antibiotics. Unfortunately, one very prevalent antibiotic, Zithromax, may be linked with serious heart complications.
FDA Issues Warnings on Zithromax
In 2012, the United States Food and Drug Administration issued a statement related to the antibiotic azithromycin (aka Zithromax, ZPak). Zithromax was a member of the macrolide class of antibiotics. Other members of this family were known to be associated with serious heart problems. However, Zithromax was believed to be the “gentle sister,” the only member of this family to lack this potentially-lethal side effects related to the electrical systems with the heart. However, a new study challenged this generally held assumption.
|
|
|
|
Thursday, 23 May 2013 08:59 |
Follow us on Twitter and Facebook for the latest Class Action Lawsuit Settlement News!
NYPD "Lucky Bag" Sting Nabs Class Action Lawsuit
By Sarah Pierce
 The NYPD has been hit with another class action lawsuit from citizens accusing the department of illegal arrest procedures.
The department has already been sued for unlawful checkpoints and its controversial “stop and frisk” program. Now the NYPD is facing legal action over its “Lucky Bag” sting operation, which tempts New Yorkers into grabbing a bag full of money or valuables.
The lead plaintiff in the NYPD “Lucky Bag” class action lawsuit is Spiridon Argyros, who says he was arrested last spring after picking up a backpack that had a wallet protruding from the pocket. Argyros says he took the wallet and placed it in a plastic bag without opening it with the intention of turning it in -- but never got a chance to. He was arrested seconds later and booked. The charges were later dismissed, but that’s not good enough for Argyros, who calls the sting operation a “trap” that treats good Samaritans like criminals.
|
|
|
|
Thursday, 23 May 2013 09:10 |
Follow us on Twitter and Facebook for the latest Yasmin, Yaz Class Action Lawsuit News!
Yasmin/Yaz Linked to Life-Threatening Blood Clots
By Robert J. Boumis
 Yaz and Yasmin were originally hailed as flagship birth control pills by their manufacturer, Bayer. These drugs were considered the third generation of oral, hormone-based contraceptives. However, serious, life-threatening risks have been linked to Yasmin and Yaz.
These birth control pills are based on a new synthetic progestin called drospirenone. This drug works similarly to other hormone-based contraceptives in that it discourages the body from releasing an egg, an effects other changes on a woman’s body that discourage pregnancy. However, it appears that drospirenone increase the serum levels of potassium, which can alter blood chemistry in such a way as to encourage the formation of blood clots. Yasmin was approved in 2001, and Yaz was approved in 2008. Both are variations on drospirenone-based drugs.
|
|
|
|
Thursday, 23 May 2013 07:54 |
Follow us on Twitter and Facebook for the latest Stevens Johnson Syndrome (SJS) Class Action Lawsuit News!
FDA: Dilantin May Increase Risk of Stevens Johnson Syndrome
By Anne Bucher
 Dilantin (phenytoin) is a drug used to treat seizures that was initially approved by the U.S. Food & Drug Administration (FDA) in the 1950s. The effectiveness of phenytoin to treat seizures was first recognized in 1938. Phenytoin suppresses abnormal brain activity that commonly occurs during an epileptic episode. Some studies have shown phenytoin to be useful to stabilize moods and to treat anxiety, although these uses have not been approved by the FDA.
FDA Warns of Significant Dilantin Side Effects
Dilantin, manufactured by Pfizer Pharmaceuticals, has been commonly used to treat epilepsy. Despite its popularity, Dilantin has been linked to several serious side effects, including Stevens Johnson Syndrome (SJS). SJS is a rare, potentially life-threatening allergic reaction that is associated with certain drugs. In 2008, the FDA issued a warning about the potential for an increased risk of SJS in patients taking Dilantin.
|
|
|
|
Thursday, 23 May 2013 09:53 |
Follow us on Twitter and Facebook for the latest Unum/UnumProvident Class Action Lawsuit News!
California Woman Takes on Unum Disability Denial
By Jessica Tyner
 Search the web for Unum horror stories, and you’ll find them in abundance. The disability and life insurance company is notorious for denying benefits with no cause, stopping payments for no reason, and basically giving policyholders a hard time during a very difficult part of their life. Unfortunately, Unum is also a pretty common company and there are thousands of policyholders around the U.S. Unless the time comes when you need to file a disability claim, or your loved one needs to file a life insurance claim, you probably haven’t had much contact with the company.
|
|
|
|
Thursday, 23 May 2013 07:48 |
Follow us on Twitter and Facebook for the latest Propecia Side Effects Class Action Lawsuit News!
Journal of Sexual Medicine Researchers Weigh in on Propecia
By Jessica Tyner
 Numerous studies have been conducted that link the anti-male pattern baldness drug Propecia to lasting sexual side effects. According to a report in the Journal of Sexual Medicine, Propecia certainly works -- but it might be a trade-off. The potential side effects of Propecia -- including erectile dysfunction, male breast growth, genital shrinkage and mood swings -- can continue long after a man stops taking Propecia.
There are so many victims of Propecia side effects that drug injury lawsuits and Propecia class action lawsuits are flourishing in 2013. When testosterone is converted to dihydrotestosterone (a more potent form of testosterone), that’s when baldness occurs. Propecia works by lowering those conversion rates. This might lead to re-grown hair, but it may come at the cost of a person’s mental health and sex life.
|
|
|
|
Thursday, 23 May 2013 07:43 |
Follow us on Twitter and Facebook for the latest Mirena Class Action Lawsuit News!
Massive Number of Mirena IUD Injury Reports Continues to Grow
By Amanda Antell
 The FDA has received over 45,000 Mirena IUD injury reports since the revelation that the popular intrauterine contraceptive can migrate and cause serious side effects. Since 2000, over 10 million women have used Mirena IUD as their form of birth control.
The Mirena IUD is a T-shaped devices implanted into the uterus to prevent pregnancy, and to treat heavy menstrual bleeding. Manufactured by Bayer Pharmaceuticals, thousands of women are reporting serious injuries and complications related to this device. The recent count in injury reports by the FDA topples over 45,000 across the nation. Despite the lawsuits and warnings from the FDA, Bayer has chosen not recall Mirena or provide any additional warnings for the millions of women using the IUD.
|
|
